WHO Addresses Cannabinoid Hyperemesis Syndrome

The WHO has added cannabinoid hyperemesis syndrome (CHS) to its diagnostic manual, establishing a new dedicated ICD-10-CM (International Classification of Diseases, 10th Revision, Clinical Modification) diagnosis code for the health condition. The update, which took effect Oct. 1, 2025, has also been adopted by the CDC. The goal was to facilitate healthcare providers in the United States to not…